Profile data is unavailable for this security.
About the company
CanaQuest Medical Corp is a Canada-based clinical-stage, life sciences company. The Company is focused on the drug discovery and development of targeted therapeutics within the endocannabinoidome, including PPAR receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and post-traumatic stress disorder (PTSD). It has created a natural formulation derived from cannabidiol + proprietary API composition. The Company has a drug candidate, CQ-001, positioned for clinical trials targeting epilepsy. Its CQ-001 drug candidate combines cannabidiol (CBD) with essential fatty acids (Omega-3s). In addition, the Company is also focused on developing a nutraceutical version of the formulation, Mentanine, which is scheduled for clinical studies to investigate its potential applications across various indications, paving the way for future clinical trials.
- Revenue in USD (TTM)0.00
- Net income in USD-790.78k
- Incorporated2008
- Employees--
- LocationCanaQuest Medical Corp4120 RIDGEWAY DRIVE, UNIT 37MISSISSAUGA L5L 5S9CanadaCAN
- Phone+1 (416) 704-3040
- Websitehttps://ir.canaquest.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pure Harvest Corporate Group Inc | 2.48m | -6.67m | 191.31k | 25.00 | -- | 0.0956 | -- | 0.0772 | -0.0901 | -0.0901 | 0.0383 | 0.0201 | 0.2644 | 1.46 | 40.64 | 99,070.40 | -70.96 | -- | -136.76 | -- | 33.83 | -- | -268.37 | -- | 0.5886 | -0.866 | 0.7639 | -- | 1,808.41 | -- | -459.26 | -- | -- | -- |
| Gelstat Corp | 1.68m | -1.22m | 210.00k | 2.00 | -- | 0.0287 | -- | 0.125 | -0.0033 | -0.0033 | 0.0046 | 0.014 | 0.3021 | 4.17 | -- | 840,285.00 | -21.96 | -- | -26.29 | -- | 28.99 | -- | -72.69 | -- | 0.3216 | -134.79 | 0.0267 | -- | -66.81 | -- | -60.17 | -- | -- | -- |
| ITonis Inc | 0.00 | -1.17m | 457.02k | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -187.63 | -- | -1,169.36 | -- | -- | -- | -- | -- | -- | -0.8999 | -- | -- | -- | -- | -506.86 | -- | -- | -- |
| Resonate Blends Inc | 751.28k | -1.88m | 590.41k | 6.00 | -- | -- | -- | 0.7859 | -0.0205 | -0.0205 | 0.0083 | -0.0244 | 0.632 | -- | 11.93 | -- | -158.40 | -680.29 | -- | -- | 46.92 | -78.88 | -250.64 | -12,895.26 | -- | -2.30 | 4.00 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
| Gold River Productions Inc. | -100.00bn | -100.00bn | 618.37k | 1.00k | -- | 0.9535 | -- | -- | -- | -- | -- | 0.0005 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -100.11 | -- | -- | -- |
| CanaQuest Medical Corp | 0.00 | -790.78k | 767.60k | -- | -- | -- | -- | -- | -0.0503 | -0.0503 | 0.00 | -0.0363 | 0.00 | -- | -- | -- | -1,084.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.42 | -- | -- | -- |
| Link Reservations Inc | 0.00 | -480.90k | 1.06m | 0.00 | -- | -- | -- | -- | -46.51 | -46.51 | 0.00 | -13.99 | 0.00 | -- | -- | -- | -246.84 | -- | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -22.69 | -- | -- | -- |
| PainReform Ltd | 0.00 | -17.67m | 1.26m | 6.00 | -- | -- | -- | -- | -41.92 | -41.92 | 0.00 | -3.53 | 0.00 | -- | -- | 0.00 | -309.43 | -55.47 | -650.22 | -68.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -6.28 | -- | -- | -- |
| Evofem Biosciences Inc | 17.71m | 57.36m | 1.32m | 37.00 | 0.0009 | -- | 0.0231 | 0.0748 | -0.4918 | -0.4918 | 0.0297 | -0.7803 | 1.57 | 1.81 | 3.61 | 478,756.80 | 534.21 | -211.64 | -- | -- | 75.75 | -- | 341.16 | -1,031.55 | 0.0841 | -4.50 | -- | -- | 8.20 | -- | 164.08 | -- | -10.59 | -- |
| Nexien Biopharma Inc | 0.00 | -239.11k | 1.42m | 0.00 | -- | -- | -- | -- | -0.0036 | -0.0036 | 0.00 | -0.0051 | 0.00 | -- | -- | -- | -1,010.82 | -1,542.27 | -- | -- | -- | -- | -- | -- | -- | -1.87 | -- | -- | -- | -- | 33.93 | -- | -- | -- |
